| COMPOSITION: | Each vial contains Ceftazidime 1000 mg & Tazobactam 125 mg with WFI |
| FORMULATION: | INJECTIONS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Unicef-T 1.125 injection contains Ceftazidime and Tazobactam, a broad-spectrum antibiotic used in the treatment of various bacterial infections, particularly those caused by Gram-negative bacteria. Ceftazidime, a cephalosporin, targets bacterial cell wall synthesis, while Tazobactam, a β-lactamase inhibitor, enhances the effectiveness of Ceftazidime by preventing the breakdown of the drug. This combination is effective in treating severe infections, including pneumonia, urinary tract infections and intra-abdominal infections. |
| SIDE EFFECTS: | Common adverse reactions may include inflammation of vein, diarrhoea, transient increases in hepatic enzymes & rash. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
